46.46.Z - Wholesale trade of pharmaceutical and medical products
47.91.Z - Intermediary retail sale, non-specialized
63.11.Z - Services related to computing infrastructure, data processing, website management (hosting), and other information services
70.21.Z - Head office activities and management consultancy
70.22.Z - Head office activities and management consultancy
72.19.Z - Scientific research and development activities
73.11.Z - Advertising agency activities
73.20.Z - Market research and public opinion polling
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,5 | 0,3 | 0,4 | 47,9 |
EBITDA | 0,5 | 0,3 | 0,4 | 45,9 |
Short time liabilities | 0,9 | 1,1 | 1,1 | -0,3 |
Equity capital | 1,6 | 1,8 | 2,1 | 17,9 |
Operating profit (EBIT) | 0,5 | 0,3 | 0,4 | 45,9 |
Assets | 2,5 | 2,9 | 3,2 | 10,9 |
Net profit (loss) | 0,4 | 0,2 | 0,4 | 72,8 |
Cash | 0,2 | 0,2 | 0,1 | -63,3 |
Net income from sale | 5,9 | 5 | 6,4 | 29,1 |
Liabilities and provisions for liabilities | 0,9 | 1,1 | 1,1 | -0,3 |
Working assets | 2,5 | 2,9 | 3,2 | 10,6 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 27,9 | 11,6 | 17,1 | 5,5 |
Equity capital to total assets | 62,2 | 61,5 | 65,4 | 3,9 |
Gross profit margin | 9,2 | 5,4 | 6,2 | 0,8 |
EBITDA Margin | 9,3 | 6,2 | 7 | 0,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 59 | 81 | 62 | -19 |
Current financial liquidity indicator | 2.646944284439087 | 2.5976340770721436 | 2.8817250728607178 | 0,3 |
Net dept to EBITDA | -0.1793074905872345 | 0.9600733518600464 | 0.7873651385307312 | -0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane